Question · asked by 1 review

G‐CSF vs placebo or no treatment: Oral mucositis (moderate to severe)

Population
Adults with cancer receiving treatment
Intervention
G‐CSF
Comparison
placebo or no treatment
Outcome
Oral mucositis (moderate to severe)

It is very uncertain whether granulocyte-colony stimulating factor (G-CSF) changes oral mucositis (moderate to severe) compared with placebo or no treatment (very low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Granulocyte-colony stimulating factor (G-CSF) vs Placebo or no treatment
Oral mucositis (moderate to severe) · Adults with cancer receiving treatment · Chemotherapy alone for breast cancer
It is very uncertain whether granulocyte-colony stimulating factor (G-CSF) changes oral mucositis (moderate to severe) compared with placebo or no treatment (very low certainty).
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and… (2017) · Cochrane All outcomes
RR 0.33 [0.12, 0.95]1 study · 14 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors
2017 · Cochrane All outcomes
2017-05Not listedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.